Therapixel

Therapixel is a leading software company specializing in the development and commercialization of Artificial Intelligence solutions for medical imaging. Their flagship product, MammoScreen®, is an AI-powered software designed to aid radiologists in interpreting screening mammograms. By harnessing the power of AI, MammoScreen® assists radiologists in the early detection of breast cancer, ultimately reducing the global burden of this disease.

Therapixel's team is dynamic and passionate about innovative technologies, working towards a shared objective of improving breast cancer detection. Their head office is located in France, reflecting their commitment to delivering cutting-edge solutions. MammoScreen® is a registered trademark of Therapixel Inc.

With its advanced features and accuracy, MammoScreen® provides an invaluable tool in the fight against breast cancer. To learn more about MammoScreen® and schedule a demo, visit their website or contact their team directly. Join Therapixel in their mission to advance medical imaging and make a difference in global healthcare